Larimar Therapeutics, Inc. ($LRMR)
Celano Michael โ Chief Financial Officer
Shares
18,460
Price
$2.71
Total Value
$49,991.53
P&L
-0.3% ($149.53)
Nearby Earnings
Nov 5, 2026
EPS:Est: -0.35
Nov 11, 2026
EPS:Est: -0.35
Nov 13, 2026
EPS:Est: -0.35
Transaction Details
| Insider | Celano Michael |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Nov 11, 2026 |
| Transaction Code | P Purchase |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Nov 12, 2026 |
| Shares Purchased | 18,460 |
| Price per Share | $2.71 |
| Total Value | $49,991.53 |
| Shares Owned After | 234,245 |
| Derivative | No |
| Accession Number | 0001193125-26-458834 |
| Document | View SEC Filing |